ICD-10 Code M31.2: Lethal midline granuloma coding guide

Key Takeaways

ICD-10 Code M31.2 is the billable ICD-10-CM code for lethal midline granuloma, effective October 1, 2025 for fiscal year 2026.

M31.2 sits within the M31 category (Other necrotizing vasculopathies) under the musculoskeletal and connective tissue chapter M00-M99.

Do not confuse M31.2 with M31.30/M31.31 (Wegener’s granulomatosis / GPA): these are distinct codes for clinically different conditions.

Most presentations historically called lethal midline granuloma are now diagnosed as nasal-type extranodal NK/T-cell lymphoma. When the record documents lymphoma, code C86.00 (not having achieved remission) or C86.01 (in remission), not M31.2.

Practice management software like Pabau validates diagnosis and billing codes such as M31.2 against payer rules and tracks claim status automatically, cutting denial risk on rare-diagnosis claims.

ICD-10 Code M31.2 is the billable ICD-10-CM code for lethal midline granuloma, a rare granulomatous vasculitis that progressively destroys midline facial structures such as the nose, sinuses, and palate. It’s the sole billable code for this condition. An adjacent M31 code, particularly M31.3x for Wegener’s granulomatosis, describes a clinically distinct disease and should not be substituted.

ICD-10 Code M31.2: Lethal midline granuloma at a glance

The table below summarizes every key detail coders need before submitting a claim with ICD-10 Code M31.2.

What is M31.2 in ICD-10-CM?

ICD-10 Code M31.2 describes lethal midline granuloma (also documented as midline lethal granuloma or midline granuloma), a rare granulomatous vasculitis that causes progressive, necrotizing destruction of midline facial structures. The condition targets the nose, nasal cavity, paranasal sinuses, and palate. On biopsy, it shows inflammatory granuloma formation with vasculitis and tissue necrosis, which sets it apart from other midline destructive processes.

Under WHO’s ICD-10 classification and its US clinical modification (ICD-10-CM), this condition is placed within M31 because the underlying pathology involves necrotizing vasculopathy, not a primary connective tissue autoimmune process. Therefore, the distinction matters for coding. Coders must confirm the clinician’s diagnosis specifies granulomatous vasculitis of the midline facial region, not Wegener’s granulomatosis (M31.3x) or eosinophilic granulomatosis with polyangiitis (M30.1).

• Primary anatomical sites: nose, nasal cavity, paranasal sinuses, hard and soft palate
• Pathological hallmark: granulomatous inflammation with necrotizing vasculitis
• Clinical presentation: progressive midline facial destruction, often with ulceration and perforation of nasal septum
• Coding distinction: M31.2 is not a catch-all for midline facial lesions – histopathological confirmation is required

When M31.2 is the wrong code

One point drives most of the coding difficulty with this diagnosis. “Lethal midline granuloma” began as a clinical description of a destructive midline syndrome, before the underlying causes were separated out. Modern pathology now attributes the majority of these presentations to nasal-type extranodal NK/T-cell lymphoma, with the remainder largely explained by granulomatosis with polyangiitis (Wegener’s).

That reclassification is the crux of the differential diagnosis, and it decides the code: M31.2 applies only when the documented diagnosis is the necrotizing vasculopathy itself. When the record names a lymphoma, the correct code is C86.00 (extranodal NK/T-cell lymphoma, nasal type, not having achieved remission) or C86.01 (in remission), not M31.2.

Practices starting treatment at that point can standardize records with a chemotherapy administration template. For patients whose diagnosis remains the vasculopathy, the disease still runs its destructive course.

Some go on to need reconstructive surgery to repair the nose or palate. Practices providing that follow-up care, including those running plastic surgery EMR, need the same coding accuracy at the reconstructive stage as at diagnosis.

For practices managing rare inflammatory conditions, accurate documentation in the clinical record from the first encounter reduces the risk of retrospective audits and coding disputes.

Code validity and billing status

M31.2 is a billable/specific ICD-10-CM code, confirmed valid for HIPAA-covered transactions for fiscal year 2026. Specifically, the 2026 edition became effective October 1, 2025, following the standard CMS annual update cycle. Also, there are no non-specific parent-code alternatives. Because M31 itself is not billable, M31.2 is the correct and only specific code for this condition.

Payer coverage for M31.2 varies. Because lethal midline granuloma is extremely rare, some payers may request additional clinical documentation before processing claims. Confirm payer-specific medical necessity requirements before submission. Practice management software like Pabau, whose claims management software runs validation rules against payer requirements before submission, can catch mismatches before a claim leaves the practice.

Where M31.2 fits in the ICD-10-CM hierarchy

Understanding the code hierarchy helps coders confirm they have selected the most specific available code and not a non-billable header. According to the CMS ICD-10 codes page, M31.2 resolves to the following classification path:

Also, M31.2 has no further subcategory extensions. In other words, it does not expand to M31.20, M31.21, or similar. The code at the four-character level is the final billable step.

Practices that routinely manage connective tissue disorders or rare vasculopathies benefit from EHR integration paired with claims validation that flags a non-billable parent category, such as M31, before the claim leaves the practice.

Approximate synonyms and applicable-to notes for M31.2

The ICD-10-CM index accepts the following terms as synonyms for ICD-10 Code M31.2. Using any of these in clinical documentation will map to M31.2 in compliant EHR systems:

• Lethal midline granuloma
• Midline lethal granuloma
• Midline granuloma

“Midline granuloma” is the shortest accepted synonym and the most commonly used in older clinical notes. When reviewing historical records for coding or auditing, encountering this term without further specification is sufficient to code M31.2 – provided the clinical context supports granulomatous vasculitis rather than another midline destructive process.

Older charts may also use historical names that do not appear in the ICD-10-CM index, such as Stewart’s granuloma, non-healing midline granuloma, or midline granuloma of the nose. These are descriptive labels, not code assignments. The shared “granuloma” root also spans clinically unrelated codes – a sun-induced dermatologic lesion such as actinic granuloma (L57.5), for instance – so matching on the word alone can steer a coder into the wrong chapter entirely.

Treat them as a prompt to confirm the documented diagnosis: they map to M31.2 only when the vasculopathy is the stated condition, and to C86.00 or C86.01 when the record specifies NK/T-cell lymphoma. A structured template library for clinical documentation reduces synonym-to-code mismatches in the coding workflow, including for other rare diagnoses such as B64.

ICD-9-CM to ICD-10-CM crosswalk for M31.2

Practices auditing historical claims or migrating legacy records need the ICD-9-CM predecessor. The crosswalk for lethal midline granuloma is a direct one-to-one mapping. Refer to ResDAC’s GEM guidance for GEM (General Equivalence Mapping) methodology when working with large claim datasets that span the October 2015 transition.

In practice, the crosswalk is clean. ICD-9-CM 446.3 maps directly to M31.2, with no approximate or combination mappings. So for practices working with claims that span the ICD-9 to ICD-10 transition, confirming the GEM forward map is the safest starting point before resubmitting any corrected claims.

Related ICD-10-CM codes in the M31 category

M31.2 is one of several billable codes within the M31 category. The full subcategory listing is essential for coders to confirm they have selected the most diagnostically accurate code. The AAPC ICD-10-CM code lookup provides a searchable reference for the complete M31 block alongside coding notes and excludes guidance.

However, M31.9 (necrotizing vasculopathy, unspecified) should not be used when the clinician has documented lethal midline granuloma. As a result, using M31.9 in place of M31.2 is a common specificity error that can prompt payer queries and slow down payment. Practices billing a companion procedure code, such as 0024B, should confirm both codes are current for the FY2026 set before submission.

Clinical documentation requirements for M31.2

Accurate use of ICD-10 Code M31.2 depends on the clinical record supporting the specific diagnosis of lethal midline granuloma. Because this condition is rare, payer medical necessity reviews are more common than for high-volume codes. For that reason, documentation must be precise.

• Histopathological confirmation: biopsy results demonstrating granulomatous inflammation with vasculitis and tissue necrosis. The pathology report must be in the patient record.
• Anatomical site specificity: the clinical note must name the affected midline structure (nose, nasal cavity, sinuses, or palate) – not just “midline facial lesion” or “granuloma NOS.”
• Clinician diagnosis statement: an attending or treating physician’s documented diagnosis of lethal midline granuloma (or an accepted synonym). Coders assign codes based on physician documentation, not inference from lab findings alone.
• Exclusion of Wegener’s granulomatosis: because M31.30/M31.31 is clinically similar and more common, documentation should confirm ANCA status or otherwise distinguish the two conditions where relevant to the clinical picture.
• Date of service alignment: confirm the code version (FY2026 effective October 1, 2025) matches the date of service for the claim period.

Using structured digital intake forms and clinical note templates that prompt for histopathological findings and anatomical site detail reduces missing documentation at the point of care – before the record reaches the coding team.

Rheumatology and ENT practices using specialist EMR software can build M31.2’s documentation requirements directly into the clinical note template, reducing retrospective query workload.

Simplify rare diagnosis coding with Pabau

Pabau's claims management tools validate codes against payer rules and track claim status automatically, helping your team submit clean claims the first time, even for rare vasculopathy diagnoses like M31.2.

Book a demo

Coding guidelines and common errors for ICD-10 Code M31.2

Lethal midline granuloma generates a predictable set of coding errors because of its rarity and its clinical overlap with other M31 conditions. These are the pitfalls most likely to affect a claim.

Wrong-code selection errors

• Coding M31.9 instead of M31.2: When a clinician documents “midline granuloma” without further specification, some coders default to M31.9 (unspecified). If the physician documentation uses an accepted synonym for lethal midline granuloma, M31.2 is correct. Query the provider only if the documentation is genuinely ambiguous.
• Coding M31.2 when the diagnosis is NK/T-cell lymphoma: Because most historical “lethal midline granuloma” cases are now diagnosed as nasal-type extranodal NK/T-cell lymphoma, a record naming the lymphoma should be coded C86.00 (not having achieved remission) or C86.01 (in remission), not M31.2. Neoplasms are excluded from the M00-M99 chapter (Type 2 Excludes, C00-D49), so a lymphoma coded to M31.2 is both clinically and structurally wrong. Read the diagnosis statement, not the historical label.
• Confusing M31.2 with M31.30/M31.31 (Wegener’s granulomatosis / GPA): Granulomatosis with polyangiitis (formerly Wegener’s) involves a clinically distinct systemic vasculitis. Lethal midline granuloma (M31.2) is confined to midline facial structures. The two are separate codes and must not be used interchangeably, even when the clinical presentations overlap. Confirm the physician diagnosis statement before assigning either code.

Billing and documentation errors

• Using M31 as a billable code: M31 is a category header. It is not billable. The claim will reject. Always code to the highest level of specificity – M31.2 in this case.
• Omitting histopathology from the record: Some coders submit M31.2 based on clinical suspicion documented in a note. Payers reviewing rare vasculopathy claims may request the biopsy report. Document its availability in the record before submission.
• ICD-9 crosswalk errors on resubmissions: Practices resubmitting pre-2015 claims sometimes incorrectly carry ICD-9 code 446.3 into an ICD-10 submission. Convert to M31.2 for all claims dated on or after October 1, 2015.

Practices that handle a mixed specialty workload including rare inflammatory conditions can review HIPAA compliance requirements for practice software to ensure their EHR and coding systems meet the transaction standards that govern ICD-10-CM claim submissions.

Conclusion

In short, ICD-10 Code M31.2 is the sole billable code for lethal midline granuloma in ICD-10-CM. The biggest risk in coding this condition is confusing it with Wegener’s granulomatosis (M31.30/M31.31), or settling for the unspecified M31.9 when the clinical documentation clearly supports M31.2.

Pabau’s claims management software validates diagnosis codes against payer rules, reconciles payments against invoices automatically, and tracks claim status in real time, cutting the retrospective query cycles that rare diagnoses tend to generate. To see how Pabau handles rare vasculopathy coding workflows, book a demo.

Continue your research

Need to check a related procedure code? 0029B is a comparable billing reference for a related clinical workflow.

Managing billing workflows across multiple rare diagnoses? best EMR software covers what to look for in a system that handles complex diagnostic code sets.

Ordering genetic workup alongside a lymphoma diagnosis? 0022G covers billing for a related molecular test.

Frequently asked questions

More about coding M31.2